Search Results - "SHIRABE, K"

Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma by Harimoto, N., Shirabe, K., Yamashita, Y.-I., Ikegami, T., Yoshizumi, T., Soejima, Y., Ikeda, T., Maehara, Y., Nishie, A., Yamanaka, T.

“…Background Sarcopenia was identified recently as a poor prognostic factor in patients with cancer. The present study investigated the effect of sarcopenia on…”
Get full text

Identification of a bona fide microRNA biomarker in serum exosomes that predicts hepatocellular carcinoma recurrence after liver transplantation by Sugimachi, K, Matsumura, T, Hirata, H, Uchi, R, Ueda, M, Ueo, H, Shinden, Y, Iguchi, T, Eguchi, H, Shirabe, K, Ochiya, T, Maehara, Y, Mimori, K

“…Background Predictive biomarkers for the recurrence of hepatocellular carcinoma (HCC) have great benefit in the selection of treatment options, including liver…”
Get full text

Clinical Outcomes of Living Liver Transplantation According to the Presence of Sarcopenia as Defined by Skeletal Muscle Mass, Hand Grip, and Gait Speed by Harimoto, N., Yoshizumi, T., Izumi, T., Motomura, T., Harada, N., Itoh, S., Ikegami, T., Uchiyama, H., Soejima, Y., Nishie, A., Kamishima, T., Kusaba, R., Shirabe, K., Maehara, Y.

“…Sarcopenia is an independent predictor of death after living-donor liver transplantation (LDLT). However, the ability of the Asian Working Group for Sarcopenia…”
Get full text

Left Lobe Living Donor Liver Transplantation in Adults by Soejima, Y., Shirabe, K., Taketomi, A., Yoshizumi, T., Uchiyama, H., Ikegami, T., Ninomiya, M., Harada, N., Ijichi, H., Maehara, Y.

“…Adult left lobe (LL) living donor liver transplantation (LDLT) has not generally been recognized as a feasible procedure because of the problem of graft size…”
Get full text

Impact of muscle volume loss on acute oral mucositis in patients undergoing concurrent chemoradiotherapy after oral cancer resection by Yamaguchi, T., Makiguchi, T., Nakamura, H., Yamatsu, Y., Hirai, Y., Shoda, K., Suzuki, K., Kim, M., Kurozumi, S., Motegi, S.I., Shirabe, K., Yokoo, S.

“…This study evaluated the association between skeletal muscle mass depletion and severe oral mucositis in patients undergoing concurrent chemoradiotherapy after…”
Get full text

Correlation Between Portal Vein Anatomy and Bile Duct Variation in 407 Living Liver Donors by Takeishi, K., Shirabe, K., Yoshida, Y., Tsutsui, Y., Kurihara, T., Kimura, K., Itoh, S., Harimoto, N., Yamashita, Y.‐I., Ikegami, T., Yoshizumi, T., Nishie, A., Maehara, Y.

“…Our aim was to determine whether variant bile duct (BD) anatomy is associated with portal vein (PV) and/or hepatic artery (HA) anatomy. We examined the…”
Get full text

Revisiting the Safety of Living Liver Donors by Reassessing 441 Donor Hepatectomies: Is a Larger Hepatectomy Complication‐Prone? by Uchiyama, H., Shirabe, K., Nakagawara, H., Ikegami, T., Toshima, T., Soejima, Y., Yoshizumi, T., Yamashita, Y.‐I., Harimoto, N., Ikeda, T., Maehara, Y.

“…Donor safety is of paramount importance in performing living donor liver transplantation (LDLT). We retrospectively reviewed donor medical records to confirm…”
Get full text

Right hepatic venous system variation in living donors: a three‐dimensional CT analysis by Watanabe, A., Yoshizumi, T., Harimoto, N., Kogure, K., Ikegami, T., Harada, N., Itoh, S., Takeishi, K., Mano, Y., Yoshiya, S., Morinaga, A., Araki, K., Kubo, N., Mori, M., Shirabe, K.

“…Background The right hepatic venous system consists of the right hepatic vein (RHV) and inferior RHVs (IRHVs). When the right posterior section is used as a…”
Get full text

Primary Graft Dysfunction After Living Donor Liver Transplantation Is Characterized by Delayed Functional Hyperbilirubinemia by Ikegami, T., Shirabe, K., Yoshizumi, T., Aishima, S., Taketomi, Y. A., Soejima, Y., Uchiyama, H., Kayashima, H., Toshima, T., Maehara, Y.

“…The purpose of this study is to propose a new concept of primary graft dysfunction (PGD) after living donor liver transplantation (LDLT), characterized by…”
Get full text

Enterovirus 68 infection in children with asthma attacks: virus‐induced asthma in Japanese children by Hasegawa, S., Hirano, R., Okamoto‐Nakagawa, R., Ichiyama, T., Shirabe, K.

Get full text

Functional Analysis of Human Hepatocytes Isolated From Chimeric Mouse Liver by Harimoto, N., Nakagawara, H., Shirabe, K., Yoshizumi, T., Itoh, S., Ikegami, T., Soejima, Y., Maehara, Y., Ishida, Y., Tateno, C., Tanaka, Y.

“…Chimeric mice with humanized liver were first established by transplanting primary human hepatocytes (PHHs) isolated from a Japanese 27-year-old donor into…”
Get full text

Effect of laparoscopic splenectomy on portal haemodynamics in patients with liver cirrhosis and portal hypertension by Kawanaka, H., Akahoshi, T., Kinjo, N., Iguchi, T., Ninomiya, M., Yamashita, Y.-I., Ikegami, T., Yoshizumi, T., Shirabe, K., Maehara, Y.

“…Background The effect of splenomegaly in patients with liver cirrhosis and portal hypertension is not fully understood. This study was designed to determine…”
Get full text

Risk factors for portal venous thrombosis after splenectomy in patients with cirrhosis and portal hypertension by Kinjo, N., Kawanaka, H., Akahoshi, T., Tomikawa, M., Yamashita, N., Konishi, K., Tanoue, K., Shirabe, K., Hashizume, M., Maehara, Y.

“…Background: Portal venous thrombosis (PVT) is a potentially fatal complication following splenectomy. Its mechanisms and risk factors are poorly understood,…”
Get full text

Functional assessment of the liver with gadolinium-ethoxybenzyl-diethylenetriamine penta-acetate-enhanced MRI in living-donor liver transplantation by Ninomiya, M., Shirabe, K., Kayashima, H., Ikegami, T., Nishie, A., Harimoto, N., Yamashita, Y., Yoshizumi, T., Uchiyama, H., Maehara, Y.

“…Background A precise estimation of the capacity of the remnant liver following partial liver resection is important. In this study, the regional function of…”
Get full text

Deceleration of Regenerative Response Improves the Outcome of Rat with Massive Hepatectomy by Ninomiya, M., Shirabe, K., Terashi, T., Ijichi, H., Yonemura, Y., Harada, N., Soejima, Y., Taketomi, A., Shimada, M., Maehara, Y.

“…Small residual liver volume after massive hepatectomy or partial liver transplantation is a major cause of subsequent liver dysfunction. We hypothesize that…”
Get full text

Value of lymph node dissection during resection of intrahepatic cholangiocarcinoma by Shimada, M., Yamashita, Y., Aishima, S., Shirabe, K., Takenaka, K., Sugimachi, K.

“…Background: Hepatectomy with extensive lymph node dissection is the standard operation for intrahepatic cholangiocarcinoma (IHCC). However, lymph node…”
Get full text

Prognostic importance of the gross classification of hepatocellular carcinoma in living donor-related liver transplantation by Shirabe, K., Aishima, S., Taketomi, A., Soejima, Y., Uchiyama, H., Kayashima, H., Ninomiya, M., Mano, Y., Maehara, Y.

“…Background: The gross classification of hepatocellular carcinoma (HCC) has been reported to be a significant prognostic factor for patients with HCC undergoing…”
Get full text

A change in the timing for starting systemic therapies for hepatocellular carcinoma: the comparison of sorafenib and lenvatinib as the first-line treatment by Hatanaka, T, Kakizaki, S, Nagashima, T, Ueno, T, Namikawa, M, Tojima, H, Takizawa, D, Naganuma, A, Arai, H, Sato, K, Harimoto, N, Shirabe, K, Uraoka, T

“…The aim of this retrospective multicenter study was to evaluate the differences in the timing for starting systemic therapies as the first-line treatment for…”
Get more information

2205 Treatment strategy for recurrent hepatocellular carcinoma after curative heaptectomy: Repeat hepatectomy vs. salvage living donor liver transplantation by Yamashita, Y.I, Shirabe, K, Ikegami, T, Yoshizumi, T, Tsujita, E, Morita, M, Maehara, Y

Get full text

Evaluation of resectability after neoadjuvant chemotherapy for primary non-resectable colorectal liver metastases: A multicenter study by Takatsuki, M, Tokunaga, S, Uchida, S, Sakoda, M, Shirabe, K, Beppu, T, Emi, Y, Oki, E, Ueno, S, Eguchi, S, Akagi, Y, Ogata, Y, Baba, H, Natsugoe, S, Maehara, Y

“…Abstract Background/Aim The Kyushu Study Group of Clinical Cancer (KSCC) previously reported the safety and efficacy of neoadjuvant chemotherapy with…”
Get full text